Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Real-Time PCR, Digital PCR, and End-Point PCR Market Size and Growth Forecast, 2026-2033 | Market to Reach USD 21.31 Billion as Precision Medicine Drives 9.2% CAGR

globenewswire.com

Real-Time PCR, Digital PCR, and End-Point PCR Market Size and Growth Forecast, 2026-2033 | Market to Reach USD 21.31 Billion as Precision Medicine Drives 9.2% CAGR Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "Real-Time PCR, Digital PCR, and End-Point PCR Market Size, Share & Trends Analysis Report by Technology, Product, Application, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global real-time PCR, digital PCR, and end-point PCR market was valued at USD 10.58 billion in 2025 and is projected to reach USD 21.31 billion by 2033, expanding at a CAGR of 9.2% from 2026 to 2033. Growth is supported by the increasing prevalence of infectious diseases, cancer, chronic conditions, and genetic disorders, alongside rising demand for early diagnosis, precision medicine, and accurate disease monitoring.

Greater use of PCR-based diagnostics for HIV, HPV, Alzheimer's disease, Streptococcal infections, Turner syndrome, Parkinson's disease, and other conditions is expanding the target patient population. According to a WHO report published in July 2025, approximately 1.3 million people globally acquired HIV. European surveillance data also recorded more than 105,922 HIV diagnoses in 2024, with several countries reporting upward trends. These developments continue to increase demand for sensitive molecular diagnostic technologies across clinical laboratories and healthcare systems.

Prenatal genetic testing represents another important growth opportunity. A CDC report from December 2025 indicated that congenital heart defects affect approximately 1% of births annually in the U.S. PCR technologies support the early detection of genetic variations, helping clinicians make timely diagnostic and treatment decisions.

Digital PCR and Precision Medicine

The growing adoption of digital PCR is strengthening the market's role in precision medicine, oncology, infectious disease monitoring, and genetic testing. Digital PCR provides absolute quantification, high sensitivity, strong reproducibility, and accurate detection of rare genetic mutations. These capabilities are supporting wider use in clinical diagnostics and advanced research applications.

Product innovation is accelerating adoption. In July 2025, Bio-Rad expanded its Droplet Digital PCR portfolio by launching the QX Continuum and QX700 systems, which support more than 400,000 assays. The expansion enhances laboratory access to scalable digital PCR solutions for precision diagnostics and high-value healthcare applications.

Multiplex PCR, Automation, and Point-of-care Testing

Advances in multiplex PCR and assay development are improving diagnostic throughput, accuracy, and laboratory productivity. Multiplex systems can detect multiple pathogens within a single test while reducing turnaround time, operational costs, and sample requirements. In November 2025, FlashDx introduced a fully automated multiplex real-time PCR system based on semi-solid phase real-time PCR technology, supporting an integrated sample-to-result workflow and rapid multi-pathogen detection.

A study published in January 2026 also presented a multiplex RT-qPCR assay capable of detecting 18 respiratory viruses simultaneously. The assay demonstrated sensitivity of up to 99.81% and specificity of 100%, highlighting the potential of multiplex testing to improve respiratory disease diagnosis and laboratory efficiency.

Demand for point-of-care and decentralized testing is also increasing. Portable and miniaturized PCR platforms support faster testing in clinics, airports, and remote locations while strengthening pandemic preparedness and on-site diagnostic capacity. At the same time, laboratories are investing in automated, high-throughput systems that can process large sample volumes with minimal manual intervention, helping reduce errors and improve operational performance.

Report Segmentation

The report analyzes market revenue, growth opportunities, competitive dynamics, and emerging trends across technology, product, application, and regional segments for 2021-2033.

Business Value of the Report

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Segment Definitions

1.2.1. Technology

1.2.2. Product

1.2.3. Application

1.2.4. Estimates and forecasts timeline

1.3. Objectives

1.3.1. Objective-1

1.3.2. Objective-2

1.3.3. Objective-3

1.4. Research Methodology

1.5. Information Procurement

1.5.1. Purchased database

1.5.2. internal database

1.5.3. Secondary sources

1.5.4. Primary research

1.6. Information or Data Analysis

1.6.1. Data analysis models

1.7. Market Formulation & Validation

1.8. Model Details

1.8.1. Commodity flow analysis

1.9. List of Secondary Sources

1.10. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Technology Snapshot

2.3. Product Snapshot

2.4. Application Snapshot

2.5. Competitive Insights

Chapter 3. Real Time PCR, Digital PCR and End-Point PCR Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook (Drug Testing Market)

3.1.2. Related/ancillary market outlook (Drug Screening Market)

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.2.3. Market Opportunity Analysis

3.2.4. Market Challenge Analysis

3.3. Real Time PCR, Digital PCR and End-Point PCR Market Analysis Tools

3.3.1. Industry Analysis - Porter's

3.3.2. PESTEL Analysis

3.4. Regulatory Framework

3.5. Reimbursement Scenario

Chapter 4. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Real Time PCR, Digital PCR and End-Point PCR Market: Technology Movement Analysis

4.3. Real Time PCR, Digital PCR and End-Point PCR Market by Technology Outlook (USD Million)

4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

4.5. Quantitative

4.5.1. Quantitative Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.5.2. Consumables & reagents

4.5.3. Instruments

4.5.4. Software & Services

4.5.5. Software & Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.6. Digital

4.6.1. Digital market estimates and forecast, 2021-2033 (USD Million)

4.6.2. Consumables & Reagents

4.6.3. Instruments

4.6.4. Software & Services

4.7. End-point PCR

4.7.1. End-point PCR market estimates and forecast, 2021-2033 (USD Million)

4.7.2. Consumables & Reagents

4.7.3. Instruments

4.7.4. Software & Services

Chapter 5. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2021-2033 (Revenue, USD Million)

5.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis

5.2. Consumables & Reagents

5.2.1. Consumables & Reagents market estimates and forecast, 2021-2033 (USD Million)

5.3. Instruments

5.3.1. Instruments market estimates and forecast, 2021-2033 (USD Million)

5.4. Software & Services

5.4.1. Software & Services market estimates and forecast, 2021-2033 (USD Million)

Chapter 6. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2021-2033 (Revenue, USD Million)

6.1. Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis

6.2. Clinical

6.2.1. Clinical market estimates and forecast, 2021-2033 (USD Million)

6.2.2. Pathogen Testing

6.2.3. Oncology Testing

6.2.4. Blood Screening

6.2.5. Liquid Biopsy Testing

6.2.6. dPCR-based Non-Invasive Prenatal Testing (NIPT)

6.2.7. Others

6.3. Research

6.3.1. Research market estimates and forecast, 2021-2033 (USD Million)

6.3.2. Stem Cell Research

6.3.3. DNA Cloning & Sequencing

6.3.4. Recombinant DNA Technology

6.3.5. Rare Mutation Detection

6.3.6. Gene Expression

6.3.7. Single-Cell Analysis

6.3.8. Microbiome Analysis

6.3.9. Copy Number Variation Analysis

6.3.10. Library Quantification (NGS)

6.3.11. Characterization of Low-fold Changes in mRNA and miRNA Expression

6.3.12. Species Identification

6.3.13. GMO Detection

6.4. Forensics and Others

Chapter 7. Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2021-2033 (Revenue, USD Million)

7.1. Regional Market Share Analysis, 2025 & 2033

7.2. Regional Market Dashboard

7.3. Global Regional Market Snapshot

7.4. Market Size & Forecasts Trend Analysis, 2021 to 2033

7.5. North America

7.5.1. U.S.

7.5.2. Canada

7.5.3. Mexico

7.6. Europe

7.6.1. UK

7.6.2. Germany

7.6.3. France

7.6.4. Italy

7.6.5. Spain

7.6.6. Norway

7.6.7. Sweden

7.6.8. Denmark

7.7. Asia-Pacific

7.7.1. Japan

7.7.2. China

7.7.3. India

7.7.4. Australia

7.7.5. South Korea

7.7.6. Thailand

7.8. Latin America

7.8.1. Brazil

7.8.2. Argentina

7.9. MEA

7.9.1. South Africa

7.9.2. Saudi Arabia

7.9.3. UAE

7.9.4. Kuwait

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, by Key Market Participants

8.2. Company/Competition Categorization

8.3. Vendor Landscape

8.4. List of key distributors and channel partners

8.5. Key customers

8.6. Key company market share analysis, 2025

8.7. Company Profiles

8.7.1. Abbott

8.7.2. QIAGEN

8.7.3. Bio-Rad Laboratories, Inc.

8.7.4. Agilent Technologies, Inc.

8.7.5. Thermo Fisher Scientific, Inc.

8.7.6. GE Healthcare

8.7.7. BioMerieux SA

8.7.8. F. Hoffmann-La Roche Ltd

8.7.9. Fluidigm Corporation

List of Tables [94]

List of Figures [83]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/r6zt8h

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.